RNA inhibits estrogen receptor binding to DNA

Area of Science:

• Molecular Biology
• Cancer Research
• Endocrinology

Background:

• Estrogen receptor (ER) plays a crucial role in the development and progression of mammary tumors.
• Aberrant ER binding to DNA is a hallmark of hormone-dependent breast cancers.
• Identifying factors that regulate ER-DNA interactions is critical for understanding tumor biology.

Purpose of the Study:

• To investigate the presence and nature of inhibitors of estrogen receptor binding to DNA in cytosol from MTW9 rat mammary tumors.
• To characterize the molecular properties of the identified inhibitor.
• To assess the specificity of the inhibitor against various RNA species.

Main Methods:

• Preparation of cytosol from MTW9 rat mammary tumors.
• Enzymatic treatments (RNase, DNase, trypsin) to identify the nature of the inhibitor.
• Extraction of RNA from tumor cytosol.
• Assay of inhibitory activity of RNA species on estrogen receptor binding to DNA.
• Testing synthetic and natural RNA polymers for inhibitory effects.

Main Results:

• Cytosol from MTW9 rat mammary tumors contains a high molecular weight inhibitor of estrogen receptor-DNA binding.
• The inhibitory activity is abolished by RNase treatment, suggesting involvement of RNA.
• RNA extracted from tumor cytosol effectively inhibits estrogen receptor binding to DNA.
• A clear specificity in inhibition was observed for different RNA species: poly(G) > poly(U) > poly(A) or poly(C).

Conclusions:

• A specific RNA molecule present in rat mammary tumor cytosol acts as an inhibitor of estrogen receptor binding to DNA.
• This RNA-based inhibition mechanism may play a role in regulating ER activity in breast cancer.
• The observed specificity suggests potential therapeutic targets for modulating ER signaling in hormone-dependent cancers.